Memphasys Ltd has released a press release.
$4.2m raise to pursue commercial opportunities with Felix
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- Board and executive transition and capital raise
- Felix System records 10 new live births in India
- Vitrolife sign Felix distribution agreement for Japanese mkt
- Felix considered best method to treat cryopreserved semen
- Japan first commercial sale and first baby born using Felix
Later from Memphasys
- Vitrolife distribution agreement expands into Canada and NZ
- AI-Port Update - Spring Field Trial Yields Positive Results
- Felix TM System Sales Orders Accelerate in Japan
- 2024 Investor Presentation
- Felix Japanese trial provides sperm preparation benefits
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys